How the bone hormone osteocalcin is controlled and could help treat conditions
Regulation of osteocalcin secretion and its therapeutic implication
Researchers are looking at how the bone-made hormone osteocalcin is released and whether changing its levels could help adults with metabolic, bone, or age-related problems.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11198010 on NIH RePORTER |
What this research studies
This project studies the bone-produced hormone osteocalcin using genetic mouse models and laboratory experiments to understand what controls its production and release. The team examines how osteocalcin interacts with other hormones and neurotransmitters and how those interactions affect bone mass, metabolism, and aging-related functions. Their work seeks molecular targets or strategies to change osteocalcin levels that could be developed into treatments. Over time this could guide tests or therapies aimed at adults with metabolic disease, low bone mass, or age-related declines.
Who could benefit from this research
Good fit: Adults with metabolic conditions (for example type 2 diabetes or insulin resistance), people with low bone mass or osteoporosis, or adults experiencing age-related metabolic or functional decline would be the most likely candidates for future related trials.
Not a fit: Children and people without metabolic, bone, or age-related concerns are unlikely to benefit directly from this early-stage, largely preclinical research.
Why it matters
Potential benefit: If successful, the work could lead to new treatments that adjust osteocalcin to improve metabolism, bone health, or age-related function in adults.
How similar studies have performed: Previous animal studies have shown osteocalcin can influence metabolism, fertility, and bone biology, but translating these findings into proven human treatments remains largely unproven.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Karsenty, Gerard — Columbia University Health Sciences
- Study coordinator: Karsenty, Gerard
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.